NASDAQ: REGN · Health Care / Biotechnology: Pharmaceutical Preparations

Regeneron Pharmaceuticals Inc.

How Regeneron Pharmaceuticals Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$84.3B

Price

$818.77

P/E

17.9

EPS (TTM)

$45.62

1-year return

25.2%

Dividend yield

0.4%

52-week range

$600.66–$852.03

Compared with

• Biotechnology: Pharmaceutical Preparations industry
• Health Care sector
• S&P 500
• NASDAQ-100

For information only, not investment advice. Data may contain errors. Disclaimer · Sources